Abstract
2-Butyl-5-methoxymethyl-6-(1-oxopyridin-2-yl)-3-[[2′-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-3H-imidazo[4,5-b]pyridine (KR31173) was radiolabeled by coupling a tetrazole-protected hydroxy precursor with [11C] methyl iodide and removing the protecting group by acid hydrolysis. In mice, the highest uptake of [11C] KR31173 was in the adrenal glands, kidneys, and liver. Tissue to blood ratios were generally greater than 10:1. Uptake of the tracer in the adrenal glands, kidneys, lungs, and heart was blocked with a 1 mg/kg dose of KR31173 or MK-996.
Original language | English (US) |
---|---|
Pages (from-to) | 571-574 |
Number of pages | 4 |
Journal | Nuclear Medicine and Biology |
Volume | 31 |
Issue number | 5 |
DOIs | |
State | Published - Jul 2004 |
Keywords
- AT
- Angiotensin
- Hypertension
- KR31173
- Mice
- PET
ASJC Scopus subject areas
- Molecular Medicine
- Radiology Nuclear Medicine and imaging
- Cancer Research